Drug Shortage Report for VOLUVEN
| Report ID | 38004 |
| Drug Identification Number | 02278057 |
| Brand name | VOLUVEN |
| Common or Proper name | Voluven |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROXYETHYL STARCH 130/0.4 |
| Strength(s) | 6% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 250 mL Bag |
| ATC code | B05AA |
| ATC description | BLOOD AND RELATED PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2018-02-01 |
| Actual start date | |
| Estimated end date | 2018-03-01 |
| Actual end date | 2018-03-05 |
| Shortage status | Resolved |
| Updated date | 2018-03-06 |
| Company comments | During the supply shortage, Voluven 500 mL Bag and Volulyte 250 mL Bag will be available for substitution. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2018-03-06 | English | Compare |
| v5 | 2018-03-02 | French | Compare |
| v4 | 2018-03-02 | English | Compare |
| v3 | 2018-02-02 | English | Compare |
| v2 | 2018-02-01 | French | Compare |
| v1 | 2018-02-01 | English | Compare |
Showing 1 to 6 of 6